Concentrix (CNXC) Financials

$56.49 -0.95 (-1.65%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$56.50 +0.01 (+0.02%)

As of 05/30/2025 04:45 PM Eastern

Annual Income Statements for Concentrix

This table shows Concentrix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	11/30/2024	11/30/2023	11/30/2022	11/30/2021	11/30/2020	11/30/2019
Net Income / (Loss) Attributable to Common Shareholders	251	314	435	406	165	117
Consolidated Net Income / (Loss)	251	314	436	406	165	117
Net Income / (Loss) Continuing Operations	251	314	436	406	165	117
Total Pre-Tax Income	299	408	605	556	268	204
Total Operating Income	596	661	640	572	309	294
Total Gross Profit	3,449	2,578	2,257	1,969	1,662	1,748
Total Revenue	9,619	7,115	6,324	5,587	4,720	4,708
Operating Revenue	9,619	7,115	6,324	5,587	4,720	4,708
Total Cost of Revenue	6,170	4,537	4,067	3,618	3,058	2,959
Operating Cost of Revenue	6,170	4,537	4,067	3,618	3,058	2,959
Total Operating Expenses	2,853	1,917	1,617	1,397	1,353	1,454
Selling, General & Admin Expense	2,853	1,917	1,617	1,397	1,353	1,454
Total Other Income / (Expense), net	-297	-253	-35	-17	-41	-90
Interest Expense	322	201	70	23	48	92
Other Income / (Expense), net	25	-52	35	6.35	7.45	2.28
Income Tax Expense	48	94	169	150	103	87
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	0.59	0.00	0.00	-
Basic Earnings per Share	$3.72	$5.72	$8.34	$7.78	$3.19	$2.27
Weighted Average Basic Shares Outstanding	64.98M	53.80M	51.35M	51.36M	51.60M	51.60M
Diluted Earnings per Share	$3.71	$5.70	$8.28	$7.70	$3.19	$2.27
Weighted Average Diluted Shares Outstanding	65.07M	54.01M	51.74M	51.91M	51.60M	51.60M
Weighted Average Basic & Diluted Shares Outstanding	64.40M	66.33M	52.07M	52.32M	-	-

This table shows Concentrix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Net Income / (Loss) Attributable to Common Shareholders	70	116	17	67	52	69	78	79	88	105	107
Consolidated Net Income / (Loss)	70	116	17	67	52	69	78	79	88	105	107
Net Income / (Loss) Continuing Operations	70	116	17	67	52	69	78	79	88	105	107
Total Pre-Tax Income	101	113	26	87	73	77	107	106	118	163	149
Total Operating Income	169	145	153	150	148	180	162	163	156	178	158
Total Gross Profit	856	871	864	858	857	823	594	580	581	593	567
Total Revenue	2,372	2,448	2,387	2,381	2,403	2,231	1,633	1,615	1,636	1,641	1,580
Operating Revenue	2,372	2,448	2,387	2,381	2,403	2,231	1,633	1,615	1,636	1,641	1,580
Total Cost of Revenue	1,516	1,577	1,523	1,523	1,546	1,408	1,039	1,034	1,055	1,047	1,013
Operating Cost of Revenue	1,516	1,577	1,523	1,523	1,546	1,408	1,039	1,034	1,055	1,047	1,013
Total Operating Expenses	687	726	711	707	708	642	431	418	425	415	409
Selling, General & Admin Expense	687	726	711	707	708	642	431	418	425	415	409
Total Other Income / (Expense), net	-68	-32	-127	-63	-76	-103	-55	-57	-38	-15	-8.19
Interest Expense	73	76	81	82	82	71	49	47	34	28	20
Other Income / (Expense), net	4.92	44	-46	19	6.82	-33	-6.17	-9.38	-3.71	13	12
Income Tax Expense	31	-2.74	9.79	20	21	7.62	29	27	30	58	42
Basic Earnings per Share	$1.04	$1.73	$0.25	$0.98	$0.76	$1.02	$1.50	$1.51	$1.69	$2.02	$2.05
Weighted Average Basic Shares Outstanding	64.04M	64.98M	64.66M	65.27M	65.66M	53.80M	51.06M	51.18M	51.15M	51.35M	51.19M
Diluted Earnings per Share	$1.04	$1.72	$0.25	$0.98	$0.76	$1.02	$1.49	$1.51	$1.68	$2.01	$2.04
Weighted Average Diluted Shares Outstanding	64.07M	65.07M	64.75M	65.33M	65.79M	54.01M	51.21M	51.39M	51.48M	51.74M	51.55M
Weighted Average Basic & Diluted Shares Outstanding	63.88M	64.40M	64.82M	65.33M	65.99M	66.33M	66.60M	52.05M	52.06M	52.07M	51.67M

This table details how cash moves in and out of Concentrix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	11/30/2024	11/30/2023	11/30/2022	11/30/2021	11/30/2020	11/30/2019
Net Change in Cash & Equivalents	-69	359	-26	27	73	138
Net Cash From Operating Activities	667	678	601	514	508	450
Net Cash From Continuing Operating Activities	667	678	601	514	508	448
Net Income / (Loss) Continuing Operations	251	314	436	406	165	117
Consolidated Net Income / (Loss)	251	314	436	406	165	117
Depreciation Expense	247	173	147	140	129	139
Amortization Expense	484	221	164	139	147	167
Non-Cash Adjustments To Reconcile Net Income	117	86	48	21	49	52
Changes in Operating Assets and Liabilities, net	-431	-117	-194	-192	18	-27
Net Cash From Investing Activities	-244	-2,109	-1,839	-79	-109	-151
Net Cash From Continuing Investing Activities	-244	-2,095	-1,839	-79	-109	-121
Purchase of Property, Plant & Equipment	-239	-181	-140	-149	-171	-111
Acquisitions	-5.50	-1,914	-1,698	-3.28	-5.56	-9.43
Purchase of Investments	0.00	0.00	-1.00	0.00	0.00	-
Other Investing Activities, net	0.00	-	-	-	68	-
Net Cash From Financing Activities	-493	1,803	1,238	-402	-335	-340
Net Cash From Continuing Financing Activities	-493	1,816	1,238	-402	-335	-192
Repayment of Debt	-2,407	-2,442	-2,514	-1,661	-1,485	0.00
Repurchase of Common Equity	-136	-64	-123	-25	0.00	-
Payment of Dividends	-84	-63	-53	-13	0.00	-
Issuance of Debt	2,197	4,396	3,931	1,316	1,150	0.00
Other Financing Activities, net	-63	-10	-2.89	-19	0.00	-192
Cash Interest Paid	282	143	68	21	0.00	-
Cash Income Taxes Paid	298	217	144	160	77	-

This table details how cash moves in and out of Concentrix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Net Change in Cash & Equivalents	46	5.42	44	-20	-99	-1,608	1,962	-28	33	-21	14
Net Cash From Operating Activities	1.41	284	192	238	-47	229	211	133	104	236	153
Net Cash From Continuing Operating Activities	1.41	284	192	238	-47	229	211	134	103	236	153
Net Income / (Loss) Continuing Operations	70	116	17	67	52	69	78	79	88	105	107
Consolidated Net Income / (Loss)	70	116	17	67	52	69	78	79	88	105	107
Depreciation Expense	55	59	60	61	68	59	38	38	38	37	37
Amortization Expense	112	116	123	129	122	101	34	47	39	43	42
Non-Cash Adjustments To Reconcile Net Income	34	36	29	23	24	23	16	34	14	7.72	5.44
Changes in Operating Assets and Liabilities, net	-269	-42	-36	-41	-313	-23	46	-64	-76	43	-38
Net Cash From Investing Activities	-51	-61	-63	-60	-61	-1,994	-44	-32	-40	-36	-166
Net Cash From Continuing Investing Activities	-51	-61	-63	-60	-61	-1,979	-44	-32	-40	-36	-166
Purchase of Property, Plant & Equipment	-51	-60	-63	-60	-56	-65	-44	-32	-40	-43	-26
Acquisitions	-0.66	-1.00	-	-0.00	-4.50	-1,914	-	-	0.00	7.19	-140
Net Cash From Financing Activities	102	-224	-85	-198	14	166	1,798	-127	-35	-218	41
Net Cash From Continuing Financing Activities	102	-224	-85	-198	14	180	1,798	-127	-35	-218	41
Repayment of Debt	-507	-615	-582	-676	-533	-938	-664	-418	-422	-564	-499
Repurchase of Common Equity	-26	-34	-39	-41	-22	-22	-27	-4.94	-10	-14	-51
Payment of Dividends	-22	-23	-20	-20	-21	-21	-14	-14	-14	-14	-13
Issuance of Debt	683	466	548	555	628	1,166	2,502	310	418	380	603
Other Financing Activities, net	-24	-18	8.24	-15	-38	-6.14	1.38	0.45	-5.71	-6.67	1.50
Effect of Exchange Rate Changes	-6.58	-	-0.37	-0.43	-5.54	-9.71	-4.07	-1.44	2.80	-2.71	-12

This table presents Concentrix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	11/30/2024	11/30/2023	11/30/2022	11/30/2021	11/30/2020
Total Assets	11,991	12,492	6,670	5,046	5,178
Total Current Assets	2,842	2,859	1,754	1,543	1,423
Cash & Equivalents	241	295	145	182	153
Accounts Receivable	1,927	1,889	1,390	1,208	1,081
Other Current Assets	675	674	218	153	189
Plant, Property, & Equipment, net	715	749	404	407	452
Total Noncurrent Assets	8,434	8,884	4,512	3,096	3,303
Goodwill	4,987	5,079	2,904	1,814	1,836
Intangible Assets	2,287	2,805	986	656	799
Noncurrent Deferred & Refundable Income Taxes	218	72	49	48	47
Other Noncurrent Operating Assets	942	929	573	579	620
Total Liabilities & Shareholders' Equity	11,991	12,492	6,670	5,046	5,178
Total Liabilities	7,952	8,349	3,974	2,426	2,875
Total Current Liabilities	1,996	2,074	1,132	968	1,009
Short-Term Debt	2.52	2.31	0.00	0.00	34
Accounts Payable	210	244	161	129	141
Accrued Expenses	977	1,016	395	352	371
Current Deferred & Payable Income Tax Liabilities	100	81	69	34	21
Current Employee Benefit Liabilities	707	731	507	453	420
Total Noncurrent Liabilities	5,956	6,274	2,842	1,458	1,867
Long-Term Debt	4,733	4,940	2,224	802	1,111
Noncurrent Deferred & Payable Income Tax Liabilities	313	414	105	109	154
Other Noncurrent Operating Liabilities	910	921	512	546	602
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,040	4,143	2,696	2,620	2,302
Total Preferred & Common Equity	4,040	4,143	2,696	2,620	2,302
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,040	4,143	2,696	2,620	2,302
Common Stock	3,684	3,583	2,428	2,356	0.00
Retained Earnings	1,192	1,024	774	392	0.00
Treasury Stock	-421	-272	-191	-57	0.00
Accumulated Other Comprehensive Income / (Loss)	-414	-192	-316	-71	-3.81

This table presents Concentrix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	2/28/2025	8/31/2024	5/31/2024	2/29/2024	8/31/2023	5/31/2023	2/28/2023	8/31/2022
Total Assets	11,895	12,208	12,079	12,243	8,450	6,560	6,623	6,750
Total Current Assets	2,961	2,850	2,716	2,782	3,702	1,752	1,748	1,717
Cash & Equivalents	308	246	207	235	2,113	153	178	176
Accounts Receivable	2,015	1,936	1,872	1,928	1,379	1,394	1,382	1,355
Other Current Assets	638	668	637	619	210	205	188	186
Plant, Property, & Equipment, net	678	733	728	730	406	394	399	390
Total Noncurrent Assets	8,257	8,625	8,635	8,731	4,341	4,413	4,476	4,642
Goodwill	4,936	5,084	5,026	5,031	2,897	2,904	2,905	2,972
Intangible Assets	2,161	2,483	2,564	2,673	873	911	949	1,026
Noncurrent Deferred & Refundable Income Taxes	236	115	112	76	48	45	45	60
Other Noncurrent Operating Assets	924	943	933	951	523	554	577	585
Total Liabilities & Shareholders' Equity	11,895	12,208	12,079	12,243	8,450	6,560	6,623	6,750
Total Liabilities	7,861	8,039	7,995	8,141	5,546	3,706	3,823	4,103
Total Current Liabilities	1,792	1,812	1,766	1,783	1,046	1,007	994	1,028
Short-Term Debt	0.46	2.86	1.59	2.71	0.00	0.00	0.00	6.25
Accounts Payable	158	211	202	202	138	149	142	114
Accrued Expenses	920	933	936	924	398	400	393	397
Current Deferred & Payable Income Tax Liabilities	128	31	39	60	39	41	71	45
Current Employee Benefit Liabilities	585	635	589	594	470	418	389	465
Total Noncurrent Liabilities	6,069	6,227	6,229	6,358	4,500	2,698	2,829	3,075
Long-Term Debt	4,901	4,909	4,924	5,034	3,973	2,131	2,220	2,401
Noncurrent Deferred & Payable Income Tax Liabilities	294	378	386	386	59	77	100	159
Other Noncurrent Operating Liabilities	874	940	919	938	468	490	509	515
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,034	4,169	4,083	4,102	2,904	2,854	2,801	2,647
Total Preferred & Common Equity	4,034	4,169	4,083	4,102	2,904	2,854	2,801	2,647
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,034	4,169	4,083	4,102	2,904	2,854	2,801	2,647
Common Stock	3,712	3,654	3,628	3,606	2,472	2,459	2,447	2,416
Retained Earnings	1,240	1,099	1,102	1,056	976	912	848	683
Treasury Stock	-449	-376	-336	-296	-242	-214	-209	-167
Accumulated Other Comprehensive Income / (Loss)	-468	-208	-310	-264	-302	-303	-286	-285

This table displays calculated financial ratios and metrics derived from Concentrix's official financial filings.

Metric	2024	2023	2022	2021	2020	2019
Period end date	11/30/2024	11/30/2023	11/30/2022	11/30/2021	11/30/2020	11/30/2019
Growth Metrics	-	-	-	-	-	-
Revenue Growth	35.20%	12.49%	13.20%	18.38%	0.25%	0.00%
EBITDA Growth	34.74%	1.75%	15.02%	44.67%	-1.60%	0.00%
EBIT Growth	1.95%	-9.75%	16.65%	83.03%	6.61%	0.00%
NOPAT Growth	-1.53%	10.29%	10.34%	119.93%	12.60%	0.00%
Net Income Growth	-19.95%	-27.96%	7.41%	146.09%	40.67%	0.00%
EPS Growth	-34.91%	-31.16%	7.53%	141.38%	40.53%	0.00%
Operating Cash Flow Growth	-1.55%	12.87%	16.83%	1.29%	12.87%	0.00%
Free Cash Flow Firm Growth	121.55%	-226.64%	-327.42%	115.21%	0.00%	0.00%
Invested Capital Growth	-2.90%	84.09%	47.36%	-1.65%	0.00%	0.00%
Revenue Q/Q Growth	2.31%	9.04%	2.83%	3.06%	0.00%	0.00%
EBITDA Q/Q Growth	4.35%	3.79%	4.44%	3.96%	0.00%	0.00%
EBIT Q/Q Growth	7.14%	-6.59%	4.97%	6.49%	0.00%	0.00%
NOPAT Q/Q Growth	1.73%	9.06%	-2.36%	16.34%	0.00%	0.00%
Net Income Q/Q Growth	22.51%	-10.15%	-4.21%	17.19%	0.00%	0.00%
EPS Q/Q Growth	23.26%	-14.80%	-4.06%	16.84%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	9.00%	-0.94%	9.80%	13.97%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	121.13%	-704.75%	4.85%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-3.39%	84.50%	-2.11%	-1.13%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	35.86%	36.23%	35.69%	35.25%	35.21%	37.14%
EBITDA Margin	14.06%	14.11%	15.60%	15.35%	12.56%	12.80%
Operating Margin	6.20%	9.30%	10.12%	10.25%	6.54%	6.25%
EBIT Margin	6.46%	8.56%	10.67%	10.36%	6.70%	6.30%
Profit (Net Income) Margin	2.61%	4.41%	6.89%	7.26%	3.49%	2.49%
Tax Burden Percent	83.94%	76.88%	72.01%	72.99%	61.52%	57.32%
Interest Burden Percent	48.18%	67.01%	89.62%	96.02%	84.72%	68.92%
Effective Tax Rate	16.06%	23.12%	27.99%	27.01%	38.48%	42.68%
Return on Invested Capital (ROIC)	5.78%	7.50%	11.50%	12.79%	11.53%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.32%	1.71%	9.63%	11.27%	6.46%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.36%	1.68%	4.89%	3.69%	2.79%	0.00%
Return on Equity (ROE)	6.14%	9.18%	16.39%	16.48%	14.32%	0.00%
Cash Return on Invested Capital (CROIC)	8.73%	-51.70%	-26.79%	14.45%	-188.47%	0.00%
Operating Return on Assets (OROA)	5.07%	6.36%	11.52%	11.32%	6.11%	0.00%
Return on Assets (ROA)	2.05%	3.28%	7.44%	7.93%	3.18%	0.00%
Return on Common Equity (ROCE)	6.14%	9.18%	16.39%	16.48%	14.32%	0.00%
Return on Equity Simple (ROE_SIMPLE)	6.22%	7.57%	16.16%	15.48%	7.16%	0.00%
Net Operating Profit after Tax (NOPAT)	501	508	461	418	190	169
NOPAT Margin	5.20%	7.15%	7.29%	7.48%	4.02%	3.58%
Net Nonoperating Expense Percent (NNEP)	5.46%	5.79%	1.88%	1.51%	5.07%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	5.70%	5.60%	9.37%	-	-	-
Cost of Revenue to Revenue	64.14%	63.77%	64.31%	64.75%	64.79%	62.86%
SG&A Expenses to Revenue	29.66%	26.94%	25.57%	25.01%	28.66%	30.89%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	29.66%	26.94%	25.57%	25.01%	28.66%	30.89%
Earnings before Interest and Taxes (EBIT)	621	609	675	579	316	297
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,352	1,004	986	858	593	602
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.72	1.48	2.27	3.21	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	55.60	0.00	0.00
Price to Revenue (P/Rev)	0.30	0.86	0.97	1.50	0.00	0.00
Price to Earnings (P/E)	11.60	19.54	14.07	20.73	0.00	0.00
Dividend Yield	2.76%	1.22%	0.87%	0.16%	0.00%	0.00%
Earnings Yield	8.62%	5.12%	7.11%	4.82%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.87	1.23	1.72	2.79	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.77	1.52	1.30	1.62	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	5.48	10.74	8.31	10.53	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	11.93	17.69	12.15	15.60	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	14.80	21.20	17.79	21.61	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	11.10	15.90	13.65	17.56	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	9.80	0.00	0.00	19.12	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	1.17	1.19	0.83	0.31	0.50	0.00
Long-Term Debt to Equity	1.17	1.19	0.83	0.31	0.48	0.00
Financial Leverage	1.12	0.98	0.51	0.33	0.43	0.00
Leverage Ratio	2.99	2.80	2.20	2.08	2.25	0.00
Compound Leverage Factor	1.44	1.88	1.98	1.99	1.91	0.00
Debt to Total Capital	53.96%	54.40%	45.21%	23.44%	33.22%	0.00%
Short-Term Debt to Total Capital	0.03%	0.03%	0.00%	0.00%	0.98%	0.00%
Long-Term Debt to Total Capital	53.94%	54.37%	45.21%	23.44%	32.24%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	46.04%	45.60%	54.79%	76.56%	66.78%	0.00%
Debt to EBITDA	3.50	4.92	2.26	0.94	1.93	0.00
Net Debt to EBITDA	3.32	4.63	2.11	0.72	1.67	0.00
Long-Term Debt to EBITDA	3.50	4.92	2.26	0.94	1.87	0.00
Debt to NOPAT	9.46	9.72	4.83	1.92	6.03	0.00
Net Debt to NOPAT	8.98	9.14	4.51	1.48	5.22	0.00
Long-Term Debt to NOPAT	9.45	9.72	4.83	1.92	5.85	0.00
Altman Z-Score	1.42	1.36	2.48	3.81	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	1.42	1.38	1.55	1.59	1.41	0.00
Quick Ratio	1.09	1.05	1.36	1.44	1.22	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	756	-3,507	-1,074	472	-3,105	0.00
Operating Cash Flow to CapEx	279.56%	375.56%	429.03%	344.90%	296.28%	404.72%
Free Cash Flow to Firm to Interest Expense	2.35	-17.45	-15.32	20.48	-64.26	0.00
Operating Cash Flow to Interest Expense	2.07	3.37	8.57	22.31	10.51	4.88
Operating Cash Flow Less CapEx to Interest Expense	1.33	2.48	6.57	15.84	6.96	3.67
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.79	0.74	1.08	1.09	0.91	0.00
Accounts Receivable Turnover	5.04	4.34	4.87	4.88	4.36	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	13.15	12.35	15.60	13.01	10.45	0.00
Accounts Payable Turnover	27.22	22.42	28.00	26.80	21.75	0.00
Days Sales Outstanding (DSO)	72.39	84.12	74.98	74.78	83.64	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	13.41	16.28	13.04	13.62	16.78	0.00
Cash Conversion Cycle (CCC)	58.98	67.84	61.94	61.17	66.86	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	8,535	8,790	4,775	3,240	3,295	0.00
Invested Capital Turnover	1.11	1.05	1.58	1.71	2.87	0.00
Increase / (Decrease) in Invested Capital	-255	4,015	1,535	-54	3,295	0.00
Enterprise Value (EV)	7,409	10,779	8,200	9,028	0.00	0.00
Market Capitalization	2,914	6,132	6,121	8,408	0.00	0.00
Book Value per Share	$62.32	$62.21	$52.18	$50.08	$44.61	$0.00
Tangible Book Value per Share	($49.90)	($56.16)	($23.11)	$2.89	($6.45)	$0.00
Total Capital	8,775	9,085	4,920	3,422	3,447	0.00
Total Debt	4,736	4,942	2,224	802	1,145	0.00
Total Long-Term Debt	4,733	4,940	2,224	802	1,111	0.00
Net Debt	4,495	4,647	2,079	620	992	0.00
Capital Expenditures (CapEx)	239	181	140	149	171	111
Debt-free, Cash-free Net Working Capital (DFCFNWC)	609	492	477	393	296	0.00
Debt-free Net Working Capital (DFNWC)	849	787	622	575	448	0.00
Net Working Capital (NWC)	847	785	622	575	415	0.00
Net Nonoperating Expense (NNE)	249	195	25	12	25	52
Net Nonoperating Obligations (NNO)	4,495	4,647	2,079	620	992	0.00
Total Depreciation and Amortization (D&A)	731	394	311	279	277	306
Debt-free, Cash-free Net Working Capital to Revenue	6.33%	6.91%	7.54%	7.03%	6.27%	0.00%
Debt-free Net Working Capital to Revenue	8.83%	11.06%	9.84%	10.29%	9.50%	0.00%
Net Working Capital to Revenue	8.80%	11.03%	9.84%	10.29%	8.79%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.72	$5.72	$8.34	$7.78	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	64.98M	53.80M	51.35M	51.36M	0.00	0.00
Adjusted Diluted Earnings per Share	$3.71	$5.70	$8.28	$7.70	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	65.07M	54.01M	51.74M	51.91M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	64.40M	66.33M	52.07M	52.32M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	501	508	461	418	190	169
Normalized NOPAT Margin	5.20%	7.15%	7.29%	7.48%	4.02%	3.58%
Pre Tax Income Margin	3.11%	5.74%	9.57%	9.95%	5.68%	4.34%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	1.93	3.03	9.63	25.11	6.55	3.22
NOPAT to Interest Expense	1.56	2.53	6.58	18.13	3.93	1.83
EBIT Less CapEx to Interest Expense	1.19	2.13	7.64	18.64	3.00	2.01
NOPAT Less CapEx to Interest Expense	0.81	1.63	4.58	11.66	0.39	0.62
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	33.36%	20.23%	12.26%	3.23%	0.00%	0.00%
Augmented Payout Ratio	87.54%	40.61%	40.57%	9.41%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Concentrix's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-1.27%	9.74%	46.21%	47.44%	46.83%	35.96%	3.37%	2.97%	6.53%	11.87%	13.05%
EBITDA Growth	-1.29%	18.33%	27.04%	50.79%	50.13%	13.55%	-8.07%	0.10%	0.14%	18.30%	10.56%
EBIT Growth	11.93%	28.05%	-31.31%	10.71%	1.92%	-22.56%	-7.98%	-3.93%	-1.95%	20.16%	7.88%
NOPAT Growth	10.84%	-8.95%	-18.20%	-4.77%	-8.34%	41.52%	4.38%	-0.10%	4.00%	-9.17%	3.63%
Net Income Growth	34.85%	66.43%	-78.58%	-15.24%	-40.71%	-33.79%	-27.53%	-30.24%	-20.51%	-15.44%	-2.40%
EPS Growth	36.84%	68.63%	-83.22%	-35.10%	-54.76%	-49.25%	-26.96%	-29.44%	-19.62%	-14.83%	-1.92%
Operating Cash Flow Growth	103.00%	24.05%	-9.36%	78.62%	-145.11%	-2.72%	38.58%	-20.32%	130.80%	29.46%	64.02%
Free Cash Flow Firm Growth	109.95%	110.47%	-1,815.36%	-2,598.57%	-1,974.06%	-171.37%	115.57%	110.72%	114.64%	-885.19%	53.05%
Invested Capital Growth	-3.10%	-2.90%	85.43%	82.14%	83.87%	84.09%	-2.33%	-0.68%	-1.93%	47.36%	48.83%
Revenue Q/Q Growth	-3.10%	2.54%	0.28%	-0.92%	7.71%	36.62%	1.12%	-1.33%	-0.26%	3.87%	0.73%
EBITDA Q/Q Growth	-6.41%	25.58%	-19.37%	5.90%	12.18%	34.83%	-4.30%	3.71%	-15.15%	9.17%	4.20%
EBIT Q/Q Growth	-8.06%	76.28%	-36.77%	9.22%	5.18%	-5.43%	1.90%	0.56%	-20.09%	12.38%	6.38%
NOPAT Q/Q Growth	-20.49%	53.45%	-16.25%	8.47%	-34.69%	37.86%	-2.49%	4.40%	0.84%	1.68%	-6.68%
Net Income Q/Q Growth	-39.25%	595.39%	-75.12%	28.28%	-25.02%	-10.50%	-1.54%	-10.27%	-16.27%	-2.04%	-5.23%
EPS Q/Q Growth	-39.53%	588.00%	-74.49%	28.95%	-25.49%	-31.54%	-1.32%	-10.12%	-16.42%	-1.47%	-4.67%
Operating Cash Flow Q/Q Growth	-99.50%	48.42%	-19.60%	608.51%	-120.44%	8.44%	58.44%	28.44%	-55.92%	54.49%	-8.90%
Free Cash Flow Firm Q/Q Growth	-2.38%	110.15%	-3.10%	2.56%	-2.66%	-1,763.12%	50.18%	-26.91%	114.87%	4.56%	-3.33%
Invested Capital Q/Q Growth	1.09%	-3.39%	0.37%	-1.15%	1.29%	84.50%	-1.41%	-0.21%	1.41%	-2.11%	0.25%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.08%	35.56%	36.20%	36.02%	35.65%	36.89%	36.36%	35.93%	35.51%	36.17%	35.89%
EBITDA Margin	14.35%	14.86%	12.14%	15.09%	14.36%	13.78%	13.97%	14.76%	14.04%	16.51%	15.70%
Operating Margin	7.12%	5.90%	6.42%	6.31%	6.18%	8.09%	9.94%	10.07%	9.54%	10.85%	9.97%
EBIT Margin	7.33%	7.72%	4.49%	7.12%	6.46%	6.62%	9.56%	9.49%	9.31%	11.62%	10.74%
Profit (Net Income) Margin	2.96%	4.72%	0.70%	2.81%	2.17%	3.11%	4.75%	4.88%	5.37%	6.40%	6.78%
Tax Burden Percent	69.70%	102.43%	62.96%	76.71%	71.55%	90.11%	72.69%	74.41%	74.25%	64.55%	71.72%
Interest Burden Percent	58.00%	59.73%	24.63%	51.38%	46.90%	52.24%	68.42%	69.18%	77.69%	85.28%	88.05%
Effective Tax Rate	30.30%	-2.43%	37.04%	23.29%	28.45%	9.89%	27.31%	25.59%	25.75%	35.45%	28.28%
Return on Invested Capital (ROIC)	5.43%	6.72%	5.59%	6.14%	5.07%	7.65%	9.78%	10.00%	9.30%	11.05%	10.79%
ROIC Less NNEP Spread (ROIC-NNEP)	4.42%	6.01%	3.14%	4.69%	3.49%	4.88%	7.81%	7.95%	7.98%	10.31%	10.39%
Return on Net Nonoperating Assets (RNNOA)	5.10%	6.71%	2.90%	4.53%	3.46%	4.80%	5.75%	5.87%	6.12%	5.24%	5.87%
Return on Equity (ROE)	10.53%	13.43%	8.49%	10.67%	8.53%	12.44%	15.53%	15.87%	15.43%	16.29%	16.66%
Cash Return on Invested Capital (CROIC)	8.94%	8.73%	-52.62%	-50.95%	-51.80%	-51.70%	12.03%	10.22%	11.44%	-26.79%	-27.67%
Operating Return on Assets (OROA)	5.82%	6.07%	4.09%	6.61%	5.40%	4.91%	8.21%	9.32%	8.97%	12.54%	11.23%
Return on Assets (ROA)	2.35%	3.71%	0.63%	2.60%	1.81%	2.31%	4.08%	4.80%	5.17%	6.91%	7.09%
Return on Common Equity (ROCE)	10.53%	13.43%	8.49%	10.67%	8.53%	12.44%	15.53%	15.86%	15.42%	16.29%	16.66%
Return on Equity Simple (ROE_SIMPLE)	6.68%	0.00%	4.92%	6.52%	6.78%	0.00%	12.03%	13.27%	14.75%	0.00%	17.18%
Net Operating Profit after Tax (NOPAT)	118	148	96	115	106	163	118	121	116	115	113
NOPAT Margin	4.96%	6.05%	4.04%	4.84%	4.42%	7.29%	7.22%	7.49%	7.08%	7.00%	7.15%
Net Nonoperating Expense Percent (NNEP)	1.01%	0.71%	2.45%	1.44%	1.58%	2.77%	1.97%	2.05%	1.32%	0.74%	0.40%
Return On Investment Capital (ROIC_SIMPLE)	1.32%	1.69%	-	-	1.16%	1.79%	-	-	-	2.34%	-
Cost of Revenue to Revenue	63.92%	64.44%	63.80%	63.98%	64.35%	63.11%	63.64%	64.07%	64.49%	63.84%	64.11%
SG&A Expenses to Revenue	28.96%	29.66%	29.78%	29.71%	29.47%	28.80%	26.42%	25.87%	25.98%	25.32%	25.91%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	28.96%	29.66%	29.78%	29.71%	29.47%	28.80%	26.42%	25.87%	25.98%	25.32%	25.91%
Earnings before Interest and Taxes (EBIT)	174	189	107	170	155	148	156	153	152	191	170
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	341	364	290	359	345	307	228	238	230	271	248
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.72	0.72	1.18	0.99	1.15	1.48	1.41	1.57	2.49	2.27	2.41
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.30	0.30	0.52	0.47	0.60	0.86	0.63	0.69	1.08	0.97	1.04
Price to Earnings (P/E)	10.80	11.60	23.97	15.14	16.95	19.54	11.69	11.82	16.87	14.07	14.02
Dividend Yield	2.81%	2.76%	1.61%	1.94%	1.63%	1.22%	1.40%	1.25%	0.79%	0.87%	0.82%
Earnings Yield	9.26%	8.62%	4.17%	6.60%	5.90%	5.12%	8.55%	8.46%	5.93%	7.11%	7.13%
Enterprise Value to Invested Capital (EV/IC)	0.87	0.87	1.08	0.99	1.07	1.23	1.25	1.34	1.86	1.72	1.76
Enterprise Value to Revenue (EV/Rev)	0.78	0.77	1.02	1.01	1.21	1.52	0.91	1.00	1.40	1.30	1.40
Enterprise Value to EBITDA (EV/EBITDA)	5.57	5.48	7.39	7.09	8.51	10.74	6.15	6.54	9.12	8.31	9.11
Enterprise Value to EBIT (EV/EBIT)	11.73	11.93	16.53	13.92	15.54	17.69	9.11	9.69	13.40	12.15	13.37
Enterprise Value to NOPAT (EV/NOPAT)	14.78	14.80	19.47	17.63	18.99	21.20	12.75	13.96	19.39	17.79	18.21
Enterprise Value to Operating Cash Flow (EV/OCF)	10.48	11.10	15.64	13.84	18.05	15.90	8.69	10.31	13.65	13.65	15.72
Enterprise Value to Free Cash Flow (EV/FCFF)	9.57	9.80	0.00	0.00	0.00	0.00	10.25	13.02	16.09	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.22	1.17	1.18	1.21	1.23	1.19	1.37	0.75	0.79	0.83	0.91
Long-Term Debt to Equity	1.22	1.17	1.18	1.21	1.23	1.19	1.37	0.75	0.79	0.83	0.91
Financial Leverage	1.15	1.12	0.92	0.97	0.99	0.98	0.74	0.74	0.77	0.51	0.56
Leverage Ratio	2.97	2.99	2.92	2.69	2.73	2.80	2.74	2.36	2.41	2.20	2.26
Compound Leverage Factor	1.72	1.79	0.72	1.38	1.28	1.46	1.87	1.63	1.87	1.88	1.99
Debt to Total Capital	54.86%	53.96%	54.09%	54.67%	55.12%	54.40%	57.78%	42.75%	44.22%	45.21%	47.63%
Short-Term Debt to Total Capital	0.01%	0.03%	0.03%	0.02%	0.03%	0.03%	0.00%	0.00%	0.00%	0.00%	0.12%
Long-Term Debt to Total Capital	54.85%	53.94%	54.06%	54.66%	55.09%	54.37%	57.78%	42.75%	44.22%	45.21%	47.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	45.14%	46.04%	45.91%	45.33%	44.88%	45.60%	42.22%	57.25%	55.78%	54.79%	52.37%
Debt to EBITDA	3.64	3.50	3.79	3.99	4.50	4.92	4.11	2.16	2.25	2.26	2.55
Net Debt to EBITDA	3.41	3.32	3.60	3.82	4.29	4.63	1.92	2.00	2.07	2.11	2.36
Long-Term Debt to EBITDA	3.64	3.50	3.79	3.99	4.50	4.92	4.11	2.16	2.25	2.26	2.54
Debt to NOPAT	9.65	9.46	9.98	9.93	10.05	9.72	8.52	4.61	4.78	4.83	5.10
Net Debt to NOPAT	9.05	8.98	9.48	9.51	9.58	9.14	3.99	4.28	4.40	4.51	4.73
Long-Term Debt to NOPAT	9.65	9.45	9.98	9.92	10.04	9.72	8.52	4.61	4.78	4.83	5.09
Altman Z-Score	1.34	1.30	1.39	1.29	1.25	1.24	1.81	2.12	2.45	2.24	2.19
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.04%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.65	1.42	1.57	1.54	1.56	1.38	3.54	1.74	1.76	1.55	1.67
Quick Ratio	1.30	1.09	1.20	1.18	1.21	1.05	3.34	1.54	1.57	1.36	1.49
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	394	403	-3,974	-3,854	-3,955	-3,853	232	154	211	-1,420	-1,487
Operating Cash Flow to CapEx	2.78%	475.02%	305.39%	396.66%	-83.61%	353.72%	481.19%	414.60%	262.38%	551.40%	584.29%
Free Cash Flow to Firm to Interest Expense	5.39	5.30	-49.17	-46.74	-47.98	-54.64	4.70	3.27	6.21	-50.59	-73.38
Operating Cash Flow to Interest Expense	0.02	3.74	2.37	2.89	-0.57	3.25	4.29	2.83	3.06	8.40	7.53
Operating Cash Flow Less CapEx to Interest Expense	-0.67	2.95	1.59	2.16	-1.25	2.33	3.40	2.14	1.89	6.88	6.24
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.79	0.79	0.91	0.93	0.84	0.74	0.86	0.98	0.96	1.08	1.05
Accounts Receivable Turnover	4.86	5.04	5.67	5.30	4.76	4.34	4.77	4.78	4.75	4.87	4.95
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	13.62	13.15	16.51	15.41	13.96	12.35	16.38	16.26	15.75	15.60	15.61
Accounts Payable Turnover	34.07	27.22	34.40	31.50	29.23	22.42	33.19	31.97	31.65	28.00	41.16
Days Sales Outstanding (DSO)	75.04	72.39	64.35	68.92	76.63	84.12	76.49	76.30	76.88	74.98	73.78
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	10.71	13.41	10.61	11.59	12.49	16.28	11.00	11.42	11.53	13.04	8.87
Cash Conversion Cycle (CCC)	64.33	58.98	53.74	57.34	64.14	67.84	65.49	64.89	65.34	61.94	64.91
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,628	8,535	8,834	8,802	8,904	8,790	4,764	4,832	4,842	4,775	4,878
Invested Capital Turnover	1.09	1.11	1.38	1.27	1.15	1.05	1.35	1.33	1.31	1.58	1.51
Increase / (Decrease) in Invested Capital	-276	-255	4,070	3,969	4,061	4,015	-114	-33	-95	1,535	1,600
Enterprise Value (EV)	7,502	7,409	9,580	8,747	9,516	10,779	5,945	6,452	9,003	8,200	8,600
Market Capitalization	2,908	2,914	4,915	4,029	4,714	6,132	4,084	4,474	6,961	6,121	6,368
Book Value per Share	$62.64	$62.32	$63.81	$61.88	$62.46	$62.21	$55.78	$54.82	$53.78	$52.18	$50.85
Tangible Book Value per Share	($47.56)	($49.90)	($52.02)	($53.14)	($54.85)	($56.16)	($16.65)	($18.44)	($20.23)	($23.11)	($25.96)
Total Capital	8,936	8,775	9,080	9,009	9,138	9,085	6,877	4,985	5,021	4,920	5,054
Total Debt	4,902	4,736	4,912	4,925	5,037	4,942	3,973	2,131	2,220	2,224	2,407
Total Long-Term Debt	4,901	4,733	4,909	4,924	5,034	4,940	3,973	2,131	2,220	2,224	2,401
Net Debt	4,594	4,495	4,665	4,718	4,802	4,647	1,861	1,978	2,042	2,079	2,231
Capital Expenditures (CapEx)	51	60	63	60	56	65	44	32	40	43	26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	861	609	795	744	767	492	544	592	576	477	519
Debt-free Net Working Capital (DFNWC)	1,169	849	1,041	951	1,002	787	2,656	745	754	622	695
Net Working Capital (NWC)	1,168	847	1,038	950	999	785	2,656	745	754	622	689
Net Nonoperating Expense (NNE)	47	32	80	48	54	93	40	42	28	9.95	5.87
Net Nonoperating Obligations (NNO)	4,594	4,495	4,665	4,718	4,802	4,647	1,861	1,978	2,042	2,079	2,231
Total Depreciation and Amortization (D&A)	167	175	183	190	190	160	72	85	77	80	78
Debt-free, Cash-free Net Working Capital to Revenue	8.98%	6.33%	8.45%	8.61%	9.73%	6.91%	8.33%	9.14%	8.96%	7.54%	8.44%
Debt-free Net Working Capital to Revenue	12.19%	8.83%	11.07%	11.00%	12.71%	11.06%	40.71%	11.51%	11.74%	9.84%	11.31%
Net Working Capital to Revenue	12.19%	8.80%	11.04%	10.98%	12.68%	11.03%	40.71%	11.51%	11.74%	9.84%	11.21%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.04	$1.73	$0.25	$0.98	$0.76	$1.02	$1.50	$1.51	$1.69	$2.02	$2.05
Adjusted Weighted Average Basic Shares Outstanding	64.04M	64.98M	64.66M	65.27M	65.66M	53.80M	51.06M	51.18M	51.15M	51.35M	51.19M
Adjusted Diluted Earnings per Share	$1.04	$1.72	$0.25	$0.98	$0.76	$1.02	$1.49	$1.51	$1.68	$2.01	$2.04
Adjusted Weighted Average Diluted Shares Outstanding	64.07M	65.07M	64.75M	65.33M	65.79M	54.01M	51.21M	51.39M	51.48M	51.74M	51.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	63.88M	64.40M	64.82M	65.33M	65.99M	66.33M	66.60M	52.05M	52.06M	52.07M	51.67M
Normalized Net Operating Profit after Tax (NOPAT)	118	101	96	115	106	163	118	121	116	115	113
Normalized NOPAT Margin	4.96%	4.13%	4.04%	4.84%	4.42%	7.29%	7.22%	7.49%	7.08%	7.00%	7.15%
Pre Tax Income Margin	4.25%	4.61%	1.11%	3.66%	3.03%	3.46%	6.54%	6.56%	7.23%	9.91%	9.46%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.38	2.48	1.33	2.06	1.88	2.09	3.17	3.24	4.48	6.79	8.37
NOPAT to Interest Expense	1.61	1.95	1.19	1.40	1.29	2.31	2.39	2.56	3.41	4.09	5.57
EBIT Less CapEx to Interest Expense	1.69	1.70	0.55	1.33	1.20	1.17	2.28	2.56	3.32	5.27	7.08
NOPAT Less CapEx to Interest Expense	0.92	1.16	0.42	0.67	0.61	1.39	1.50	1.88	2.24	2.57	4.29
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	31.77%	33.36%	39.89%	28.50%	25.10%	20.23%	16.37%	14.76%	13.23%	12.26%	11.48%
Augmented Payout Ratio	83.84%	87.54%	100.18%	70.34%	52.30%	40.61%	32.38%	35.98%	45.51%	40.57%	41.04%

Frequently Asked Questions About Concentrix's Financials

When does Concentrix's fiscal year end?

According to the most recent income statement we have on file, Concentrix's financial year ends in November. Their financial year 2024 ended on November 30, 2024.

How has Concentrix's net income changed over the last 5 years?

Concentrix's net income appears to be on an upward trend, with a most recent value of $251.22 million in 2024, rising from $117.16 million in 2019. The previous period was $313.84 million in 2023. See Concentrix's forecast for analyst expectations on what’s next for the company.

What is Concentrix's operating income?

Concentrix's total operating income in 2024 was $596.39 million, based on the following breakdown:

Total Gross Profit: $3.45 billion
Total Operating Expenses: $2.85 billion

How has Concentrix revenue changed over the last 5 years?

Over the last 5 years, Concentrix's total revenue changed from $4.71 billion in 2019 to $9.62 billion in 2024, a change of 104.3%.

How much debt does Concentrix have?

Concentrix's total liabilities were at $7.95 billion at the end of 2024, a 4.8% decrease from 2023, and a 176.5% increase since 2020.

How much cash does Concentrix have?

In the past 4 years, Concentrix's cash and equivalents has ranged from $145.38 million in 2022 to $295.34 million in 2023, and is currently $240.57 million as of their latest financial filing in 2024.

How has Concentrix's book value per share changed over the last 5 years?

Over the last 5 years, Concentrix's book value per share changed from 0.00 in 2019 to 62.32 in 2024, a change of 6,232.3%.

Related Companies

This page (NASDAQ:CNXC) was last updated on 6/1/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Concentrix (CNXC) Financials

Frequently Asked Questions About Concentrix's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Concentrix (CNXC) Financials

Annual Income Statements for Concentrix

Quarterly Income Statements for Concentrix

Annual Cash Flow Statements for Concentrix

Quarterly Cash Flow Statements for Concentrix

Annual Balance Sheets for Concentrix

Quarterly Balance Sheets for Concentrix

Annual Metrics And Ratios for Concentrix

Quarterly Metrics And Ratios for Concentrix

Frequently Asked Questions About Concentrix's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools